• Mineralys Therapeutics (MLYS) Following Russell Index Removal Still Looks Cheap On Fair Value simplywall.st Fri, 10 Jul 2026 01:50:06 GMT
• Mineralys (MLYS) reports 2,171-share exercise; Rodman sales listed Stock Titan Thu, 09 Jul 2026 20:10:57 GMT
• AstraZeneca's Baxfendy Set For Blockbuster Sales After Hypertension Approval Seeking Alpha Thu, 09 Jul 2026 08:08:00 GMT
• Did Index Removal, ENDO 2026 Data and a $150M Raise Just Shift Mineralys Therapeutics' (MLYS) Investment Narrative? Sahm Mon, 06 Jul 2026 07:00:00 GMT
• A $500 Million Funding Deal Could Make Mineralys Therapeutics (MLYS) Stock A Multibagger Yahoo Finance Fri, 03 Jul 2026 13:41:13 GMT
• Have Insiders Sold Mineralys Therapeutics Shares Recently? simplywall.st Fri, 03 Jul 2026 11:43:43 GMT
• Is Mineralys Therapeutics, Inc. (MLYS) Stock a Biotech Opportunity With Lorundrostat’s Expanding Cardiovascular Potential? Yahoo Finance Thu, 02 Jul 2026 19:58:14 GMT
• Mineralys Therapeutics (MLYS) Left Key Russell Indexes, Is The Stock Still Below Fair Value? simplywall.st Wed, 01 Jul 2026 19:57:49 GMT
• Mineralys Therapeutics to Present Late-Breaking Data on Lorundrostat at The Endocrine Society Annual Meeting (ENDO 2026) 富途牛牛 Wed, 01 Jul 2026 11:07:30 GMT
• Mineralys Therapeutics Insider Sold Shares Worth $1,960,601, According to a Recent SEC Filing Moomoo Wed, 01 Jul 2026 08:10:31 GMT
• 5 best up and coming pharmaceutical stocks to buy now Insider Monkey Wed, 01 Jul 2026 05:52:53 GMT
• insider sell: ceo jon congleton sells 75,000 shares of mineralys therapeutics inc (mlys) GuruFocus Wed, 01 Jul 2026 00:43:18 GMT
• Form 4 Mineralys Therapeutics Inc For: 30 June By Investing.com Investing.com Nigeria Tue, 30 Jun 2026 23:30:55 GMT
• Mineralys Therapeutics (MLYS) Form 144 lists 90,730 shares sold and RSU vesting Stock Titan Tue, 30 Jun 2026 20:20:44 GMT
• Mineralys Therapeutics CCO Eric Warren sells $2.7m in shares Investing.com Tue, 30 Jun 2026 07:00:00 GMT
• Mineralys Therapeutics (MLYS) CEO sells 75K shares under Rule 10b5-1 plan Stock Titan Tue, 30 Jun 2026 07:00:00 GMT
• Mineralys (NASDAQ: MLYS) CCO sells shares after option exercise Stock Titan Tue, 30 Jun 2026 07:00:00 GMT
• Mineralys Therapeutics CEO Jon Congleton sells $1.96m in stock By Investing.com Investing.com Canada Tue, 30 Jun 2026 07:00:00 GMT
• Insider Sell: CEO Jon Congleton Sells 75,000 Shares of Mineralys Therapeutics Inc (MLYS) GuruFocus Tue, 30 Jun 2026 07:00:00 GMT
• form 144 mineralys therapeutics for: 29 june by investing.com Investing.com Nigeria Mon, 29 Jun 2026 13:42:38 GMT
• Mineralys Therapeutics (NASDAQ: MLYS) flagged sale of 104,124 shares via cashless exercise Stock Titan Mon, 29 Jun 2026 13:06:19 GMT
• Mineralys Therapeutics, Inc.(NasdaqGS:MLYS) dropped from Russell Microcap Growth Benchmark Index marketscreener.com Mon, 29 Jun 2026 12:38:31 GMT
• Mineralys Therapeutics, Inc.(NasdaqGS: MLYS) dropped from Russell Microcap Index marketscreener.com Mon, 29 Jun 2026 05:53:40 GMT
• Enterprise value to EBITDA forward of Mineralys Therapeutics, Inc. – NASDAQ:MLYS TradingView Sun, 28 Jun 2026 10:00:03 GMT
• Mineralys Therapeutics, Inc.(NasdaqGS: MLYS) dropped from Russell 3000E Index marketscreener.com Sun, 28 Jun 2026 07:00:00 GMT
• price to earnings forward of mineralys therapeutics, inc. – nasdaq:mlys TradingView Sun, 28 Jun 2026 03:03:37 GMT
• enterprise value to ebit forward of mineralys therapeutics, inc. – nasdaq:mlys TradingView Sat, 27 Jun 2026 19:29:38 GMT
• understanding the setup: (mlys) and scalable risk Stock Traders Daily Sat, 27 Jun 2026 18:54:01 GMT
• enterprise value to revenue forward of mineralys therapeutics, inc. – nasdaq:mlys TradingView Sat, 27 Jun 2026 17:05:58 GMT
• what a $350,000 insider sale might mean for mineralys ahead of december fda decision AOL.com Sat, 27 Jun 2026 10:44:58 GMT
• mineralys therapeutics, inc. actuals & estimates (nasdaq:mlys) TradingView Fri, 26 Jun 2026 19:37:13 GMT
• what a $350,000 insider sale might mean for mineralys ahead of december fda decision AOL.com Wed, 24 Jun 2026 11:43:38 GMT
• mineralys therapeutics (mlys) is up 6.8% after new lorundrostat heart failure biomarker data - what's changed simplywall.st Wed, 24 Jun 2026 07:00:00 GMT
• mineralys therapeutics (mlys) stock could be 52% undervalued after funding deal and lorundrostat data Sahm Tue, 23 Jun 2026 08:24:34 GMT
• What a $350,000 Insider Sale Might Mean for Mineralys Ahead of December FDA Decision Yahoo Finance Tue, 23 Jun 2026 07:00:00 GMT
• mineralys therapeutics (mlys) stock could be 52% undervalued after funding deal and lorundrostat data simplywall.st Mon, 22 Jun 2026 07:00:00 GMT
• mineralys therapeutics inc (mlys) earnings forecast: future eps & revenue growth estimates TradingKey Thu, 18 Jun 2026 16:25:04 GMT
• mineralys therapeutics (mlys) edges higher as shares hold above key support - sign of strength Město Břeclav Thu, 18 Jun 2026 15:31:12 GMT
• mineralys therapeutics inc (mlys) financial health: profitability & balance sheet analysis TradingKey Thu, 18 Jun 2026 11:28:33 GMT
• mineralys therapeutics inc (mlys) institutional confidence TradingKey Thu, 18 Jun 2026 08:07:45 GMT
• mineralys: limited differentiation makes lorundrostat a weak competitor Seeking Alpha Thu, 18 Jun 2026 02:58:06 GMT
• mineralys stock: limited differentiation makes lorundrostat a weak competitor (mlys) Seeking Alpha Thu, 18 Jun 2026 02:58:06 GMT
• mineralys therapeutics inc (mlys) technical analysis: support, resistance, indicators & moving averages TradingKey Thu, 18 Jun 2026 01:57:55 GMT
• mineralys therapeutics inc (mlys) valuation: pe, pb & fair value analysis TradingKey Thu, 18 Jun 2026 01:47:07 GMT
• mineralys therapeutics cmo rodman sells $350,086 in stock by investing.com Investing.com India Thu, 18 Jun 2026 01:33:14 GMT
• mineralys therapeutics (mlys) cmo sells 14,474 shares, exercises options Stock Titan Thu, 18 Jun 2026 01:30:37 GMT
• director at mineralys therapeutics (mlys) trades 3,000 shares under 10b5-1 plan Stock Titan Thu, 18 Jun 2026 01:30:36 GMT
• mineralys therapeutics director karydas sells $75,000 in stock Investing.com Thu, 18 Jun 2026 01:23:45 GMT
• mineralys therapeutics inc (mlys) risk assessment: volatility, financial risk & investment risk TradingKey Thu, 18 Jun 2026 01:21:51 GMT
• mineralys therapeutics inc (mlys) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Thu, 18 Jun 2026 00:59:31 GMT
• mineralys therapeutics inc (mlys) dividends & stock splits: historical payouts and event timeline TradingKey Wed, 17 Jun 2026 22:55:50 GMT
• mineralys therapeutics inc (mlys) shareholder structure: major shareholders & institutional holdings TradingKey Wed, 17 Jun 2026 22:52:36 GMT
• Mineralys Therapeutics (MLYS) Prices $150M Public Offering of Common Stock Yahoo Finance Wed, 17 Jun 2026 07:00:00 GMT
• Mineralys Stock: Limited Differentiation Makes Lorundrostat A Weak Competitor (MLYS) Seeking Alpha Wed, 17 Jun 2026 07:00:00 GMT
• Mineralys Therapeutics CMO Rodman sells $350,086 in stock Investing.com Wed, 17 Jun 2026 07:00:00 GMT
• Mineralys Therapeutics director Karydas sells $75,000 in stock Investing.com Wed, 17 Jun 2026 07:00:00 GMT
• Mineralys Therapeutics (NASDAQ: MLYS) files Form 144 to sell 4,584 shares Stock Titan Wed, 17 Jun 2026 07:00:00 GMT
• Mineralys Therapeutics (MLYS) Rule 144: 3,000-share cashless exercise Stock Titan Wed, 17 Jun 2026 07:00:00 GMT
• Director at Mineralys Therapeutics (MLYS) trades 3,000 shares under 10b5-1 plan Stock Titan Wed, 17 Jun 2026 07:00:00 GMT
• Mineralys Therapeutics (MLYS) CMO sells 14,474 shares, exercises options Stock Titan Wed, 17 Jun 2026 07:00:00 GMT
• mineralys: limited differentiation makes lorundrostat a weak competitor Seeking Alpha Wed, 17 Jun 2026 07:00:00 GMT
• the technical signals behind (mlys) that institutions follow Stock Traders Daily Tue, 16 Jun 2026 17:42:02 GMT
• mineralys therapeutics inc (mlys) technical analysis: support, resistance, indicators & moving averages TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• mineralys therapeutics stock trades up to $23.82 as mineralys therapeutics posts hypertension insights Traders Union Mon, 15 Jun 2026 18:58:08 GMT
• Mineralys Therapeutics (MLYS) affiliate lists multi-date sales and a 3,542-share exercise Stock Titan Mon, 15 Jun 2026 07:00:00 GMT
• new heart failure biomarkers for lorundrostat could be a game changer for mineralys therapeutics (mlys) Sahm Mon, 15 Jun 2026 07:00:00 GMT
• Mineralys Therapeutics Presents Late-Breaking Data on Lorundrostat and Heart Failure Risk Biomarkers at The Endocrine Society Annu... GlobeNewswire Sun, 14 Jun 2026 07:00:00 GMT
• Blood protein shifts hint at heart failure pathways for lorundrostat Stock Titan Sun, 14 Jun 2026 07:00:00 GMT
• mineralys therapeutics reports significant reductions in heart failure risk biomarkers associated with lorundrostat in proteomic a... Quiver Quantitative Sun, 14 Jun 2026 07:00:00 GMT
• Mineralys Therapeutics (MLYS) CMO sells 8,519 shares after option exercises Stock Titan Fri, 12 Jun 2026 07:00:00 GMT
• mineralys therapeutics (nasdaq: mlys) files rule 144 disclosing 6,349‑share cashless exercise Stock Titan Fri, 12 Jun 2026 07:00:00 GMT
• mineralys data presentation highlights heart failure biomarkers ahead of fda review MyChesCo Fri, 12 Jun 2026 07:00:00 GMT
• transcript : mineralys therapeutics, inc. presents at goldman sachs 47th annual global healthcare conference 2026, jun-09-2026 02 marketscreener.com Thu, 11 Jun 2026 07:07:44 GMT
• Mineralys Therapeutics (MLYS) to Repurchase Potential Royalties for Lorundrostat Yahoo Finance Thu, 11 Jun 2026 07:00:00 GMT
• A Look At Mineralys Therapeutics (MLYS) Valuation After New Lorundrostat Biomarker Data And Funding Update Sahm Thu, 11 Jun 2026 07:00:00 GMT
• mineralys therapeutics announces royalty repurchase, $500 million debt facility, and $150 million equity offering Global Legal Chronicle Thu, 11 Jun 2026 00:00:00 GMT
• mineralys therapeutics stock consolidates near $24.55 as weekly rebound slows amid ongoing technical pressure Traders Union Wed, 10 Jun 2026 07:00:00 GMT
• mineralys therapeutics (nasdaq: mlys) insider files sale of 2,170 shares Stock Titan Wed, 10 Jun 2026 07:00:00 GMT
• mlys: lorundrostat advances toward launch with strong clinical data, strategic deals, and broad payer support TradingView Tue, 09 Jun 2026 19:41:05 GMT
• velan capital drops 140,000 mineralys therapeutics (mlys) shares worth $4.1 million AOL.com Tue, 09 Jun 2026 08:18:24 GMT
• mineralys restructures drug economics with $500 million financing MyChesCo Tue, 09 Jun 2026 07:00:00 GMT
• lorundrostat: redefining hypertension care by targeting heart failure risk BriefGlance Mon, 08 Jun 2026 11:00:00 GMT
• Mineralys Therapeutics to Present Late-Breaking Data on GlobeNewswire Mon, 08 Jun 2026 07:00:00 GMT
• Mineralys Therapeutics to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference GlobeNewswire Mon, 08 Jun 2026 07:00:00 GMT
• Biopharma Mineralys joins Goldman Sachs health-care talks in Miami Stock Titan Mon, 08 Jun 2026 07:00:00 GMT
• mineralys therapeutics stock edges lower amid oversold conditions and consolidation risk in $21–$25 range Traders Union Mon, 08 Jun 2026 07:00:00 GMT
• latham advises mineralys therapeutics in unique three-pronged transaction — royalty repurchase, debt financing, and equity offerin... Legal Desire Media and Insights Mon, 08 Jun 2026 06:19:41 GMT
• velan capital drops 140,000 mineralys therapeutics (mlys) shares worth $4.1 million AOL.com Mon, 08 Jun 2026 06:15:36 GMT
• Mineralys Deepens Lorundrostat Bet With Royalty Buyout And New Data Yahoo Finance Sun, 07 Jun 2026 07:00:00 GMT
• Mineralys Therapeutics Stock In Shambles: Down -25% With 6-Day Losing Streak Trefis Sat, 06 Jun 2026 07:00:00 GMT
• Mineralys Therapeutics Stock Plummets 25% With 6-Day Losing Streak Trefis Sat, 06 Jun 2026 07:00:00 GMT
• Mineralys Therapeutics (MLYS) Shares Encouraging Data for Lorundrostat Clinical Efficacy Yahoo Finance Fri, 05 Jun 2026 07:00:00 GMT
• Precision Trading with Mineralys Therapeutics Inc. (MLYS) Risk Zones Stock Traders Daily Fri, 05 Jun 2026 07:00:00 GMT
• Latham Advises Mineralys Therapeutics in Unique Three-Pronged Latham & Watkins LLP Thu, 04 Jun 2026 07:00:00 GMT
• Mineralys pays up to $300 million to clear lorundrostat royalties The Pharma Letter Thu, 04 Jun 2026 07:00:00 GMT
• goldman sachs maintains mineralys therapeutics(mlys.us) with buy rating, maintains target price $42 Moomoo Thu, 04 Jun 2026 07:00:00 GMT
• mineralys announces $150 million equity offering and financing TipRanks Wed, 03 Jun 2026 21:03:54 GMT
• mineralys to repurchase future royalty payments in tanabe license agreement TipRanks Wed, 03 Jun 2026 18:11:15 GMT
• a look at mineralys therapeutics (mlys) valuation after recent share price weakness simplywall.st Wed, 03 Jun 2026 16:34:43 GMT
• mineralys secures lorundrostat rights and major financing facility TipRanks Wed, 03 Jun 2026 10:45:52 GMT
• mineralys therapeutics files form 8-k announcing material definitive agreement and company details Minichart Wed, 03 Jun 2026 10:29:00 GMT
• press release: mineralys therapeutics announces repurchase of royalty obligations in tanabe license agreement and concurrent finan... Moomoo Wed, 03 Jun 2026 10:00:00 GMT
• Mineralys Therapeutics Announces Pricing of $150 Million Underwritten Offering of Common Stock GlobeNewswire Wed, 03 Jun 2026 07:00:00 GMT
• Mineralys Therapeutics Announces Repurchase of Royalty GlobeNewswire Wed, 03 Jun 2026 07:00:00 GMT
• Ahead of FDA decision, Mineralys pays $200M to eliminate royalties on lorundrostat FirstWord Pharma Wed, 03 Jun 2026 07:00:00 GMT
• Biotech Mineralys raises $150M to help fund $200M royalty deal Stock Titan Wed, 03 Jun 2026 07:00:00 GMT
• Mineralys Therapeutics Prices Underwritten Offering of 5.6 Million Shares at $26.50 Per Share, Expected to Raise $150 Million Quiver Quantitative Wed, 03 Jun 2026 07:00:00 GMT
• Mineralys Locks In Royalty-Free Lorundrostat Rights With $200M Payment, Secures $500M Term Loan TradingView Wed, 03 Jun 2026 07:00:00 GMT
• Mineralys prices $150 million stock offering at $26.50 per share Investing.com Wed, 03 Jun 2026 07:00:00 GMT
• Mineralys makes money moves before looming hypertension approval Endpoints News Wed, 03 Jun 2026 07:00:00 GMT
• Mineralys raises $750M through debt, equity and royalty deal Investing.com Wed, 03 Jun 2026 07:00:00 GMT
• Mineralys (Nasdaq: MLYS) prices $150M stock sale to fund $200M royalty buyback Stock Titan Wed, 03 Jun 2026 07:00:00 GMT
• hypertension drug maker mineralys lines up $500m loan, $150m stock sale Stock Titan Wed, 03 Jun 2026 07:00:00 GMT
• mineralys therapeutics announces $200 million royalty repurchase and secures $500 million debt facility Quiver Quantitative Wed, 03 Jun 2026 07:00:00 GMT
• biopharma credit provides up to $150m loan to mineralys Investing.com Wed, 03 Jun 2026 07:00:00 GMT
• mineralys prices $150 million stock offering, repurchases lorundrostat royalty obligations marketscreener.com Wed, 03 Jun 2026 07:00:00 GMT
• mineralys (mlys) raises ~$150m in $26.50/share offering to fund royalty repurchase Stock Titan Wed, 03 Jun 2026 07:00:00 GMT
• mineralys (nasdaq: mlys) gets $500m loan, ends lorundrostat royalty payments Stock Titan Wed, 03 Jun 2026 07:00:00 GMT
• mineralys therapeutics, inc. enters into senior secured term loan agreement for up to $500 million marketscreener.com Wed, 03 Jun 2026 07:00:00 GMT
• wall street analysts are bullish on top healthcare picks The Globe and Mail Tue, 02 Jun 2026 07:00:00 GMT
• velan capital sells 140000 shares of mineralys therapeutics HarianBasis.co Mon, 01 Jun 2026 23:28:15 GMT
• velan capital cuts mineralys therapeutics stake by 140000 shares asatunews.co.id Mon, 01 Jun 2026 23:11:00 GMT
• mineralys therapeutics, inc. (mlys) presents at 35th european meeting on hypertension and cardiovascular protection - slideshow (n... Seeking Alpha Mon, 01 Jun 2026 07:00:00 GMT
• jefferies reiterates hold on mineralys stock amid m&a speculation Investing.com Mon, 01 Jun 2026 07:00:00 GMT
• lifesci capital maintains mineralys therapeutics(mlys.us) with buy rating, maintains target price $54 Moomoo Mon, 01 Jun 2026 07:00:00 GMT
• h.c. wainwright reiterates mineralys stock rating at buy Investing.com Mon, 01 Jun 2026 07:00:00 GMT
• breaking health news: revolutionary treatments and global health challenges Devdiscourse Mon, 01 Jun 2026 04:56:06 GMT
• velan capital drops 140,000 mineralys therapeutics (mlys) shares worth $4.1 million AOL.com Mon, 01 Jun 2026 00:19:33 GMT
• Velan Capital Drops 140,000 Mineralys Therapeutics (MLYS) Shares Worth $4.1 Million The Motley Fool Sun, 31 May 2026 07:00:00 GMT
• mineralys presents lorundrostat data in kidney disease patients by investing.com Investing.com Nigeria Sun, 31 May 2026 00:34:42 GMT
• mineralys’ pill cuts blood pressure in kidney disease patients The Mighty 790 KFGO Sat, 30 May 2026 20:24:48 GMT
• Mineralys Therapeutics Presents New Data from the Phase 3 GlobeNewswire Sat, 30 May 2026 07:00:00 GMT
• Trial pill lowers blood pressure, kidney damage marker in CKD Stock Titan Sat, 30 May 2026 07:00:00 GMT
• Mineralys Therapeutics Reports Positive Phase 3 Results for Lorundrostat in Reducing Blood Pressure and Albuminuria in Chronic Kid... Quiver Quantitative Sat, 30 May 2026 07:00:00 GMT
• Phase III LAUNCH-HTN data for Mineralys’ lorundrostat The Pharma Letter Sat, 30 May 2026 07:00:00 GMT
• mineralys presents lorundrostat data in kidney disease patients Investing.com Sat, 30 May 2026 07:00:00 GMT
• lorundrostat shows significant blood pressure and kidney benefits in ckd patients in phase 3 trial Pluang Sat, 30 May 2026 07:00:00 GMT
Mineralys Therapeutics, Inc.(NASDAQ:MLYS) 
Mineralys Therapeutics, Inc., a clinical-stage biopharmaceutical company that develops therapies for the treatment of hypertension and associated cardiovascular diseases. It clinical-stage product candidate is lorundrostat, a proprietary, orally administered, highly selective aldosterone synthase in...
Website: https://mineralystx.com
Founded: 2019
IPO Price: $16 (Feb 10, 2023)
CEO: Jon Congleton
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends